author-photo

Rohinton Tarapore

University of Pennsylvania

122

Papers

1109

Citations

Citation Trend

Filter By

Papers (86) Sort By

Journal Conference Others

Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1440: Novel imipridone ONC206 suppresses ovarian cancer progression through modulating immune cell response

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Single agent activity of ONC201 in non-midline H3 K27M-mutant diffuse gliomas

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
ONC201 shows anti-cancer activity against medullary thyroid cancer via transcriptional inhibition of RET, VEGFR2, and IGFBP2

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
CTNI-27. SINGLE AGENT ACTIVITY OF ONC201 IN NON-MIDLINE H3 K27M-MUTANT DIFFUSE GLIOMAS

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1370: ADME and toxicology profiles of first-in-class DRD2/ClpP-targeted imipridone ONC201

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5321: Novel imipridone ONC206 inhibits cell proliferation and induces apoptosis in uterine serous cancer through altering MAPK/AKT signaling network and metabolic reprogramming

2020
Show All
- Source
- Cite
- Save
Citations (0)
CTNI-37. EFFICACY OF ONC201 IN PATIENTS WITH ONC201 FOR RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
DIPG-57. TRANSCRIPTOMIC AND PROTEOMIC ANALYSES OF DIPG RESPONSE TO ONC201

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)